Auro Impex & Chemicals Board of Directors

Get the latest insights into the leadership at Auro Impex & Chemicals. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Madhusudan Goenka Managing Director
Mr. Praveen Kumar Goenka Whole Time Director
Ms. Vanshika Goenka Non Exe.Non Ind.Director
Mr. Sibasis Mitra Ind. Non-Executive Director
Mr. Sankar Thakur Ind. Non-Executive Director

Auro Impex & Chemicals Share price

AUROIMPEX

48.5

1.05 (2.21%)
NSE
BSE
Last updated on 3 Sep, 2025 | 15:14 IST
BUYSELL
Today's High

48.50

Today's Low

48.45

52 Week Low

43.95

52 Week High

90.10

The current prices are delayed, login to your account for live prices

Auro Impex & Chemicals FAQs

The board at Auro Impex & Chemicals consists of experienced professionals, including Mr. Madhusudan Goenka , Mr. Praveen Kumar Goenka , and others, overseeing the company’s strategic and corporate governance.

Directors at Auro Impex & Chemicals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Madhusudan Goenka is the current chairman at Auro Impex & Chemicals.

Executive directors at Auro Impex & Chemicals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Auro Impex & Chemicals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Auro Impex & Chemicals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.